These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
306 related articles for article (PubMed ID: 32652200)
1. Effect of sodium-glucose co-transporter 2 inhibitors on lipid profile: A systematic review and meta-analysis of 48 randomized controlled trials. Sánchez-García A; Simental-Mendía M; Millán-Alanís JM; Simental-Mendía LE Pharmacol Res; 2020 Oct; 160():105068. PubMed ID: 32652200 [TBL] [Abstract][Full Text] [Related]
2. SGLT2-inhibition increases total, LDL, and HDL cholesterol and lowers triglycerides: Meta-analyses of 60 randomized trials, overall and by dose, ethnicity, and drug type. Bechmann LE; Emanuelsson F; Nordestgaard BG; Benn M Atherosclerosis; 2024 Jul; 394():117236. PubMed ID: 37582673 [TBL] [Abstract][Full Text] [Related]
3. Effect of sodium-glucose co-transporter 2 inhibitors on hepatic parameters: A systematic review and meta-analysis of randomized controlled trials. Simental-Mendía M; Sánchez-García A; Rodríguez-Ramírez M; Simental-Mendía LE Pharmacol Res; 2021 Jan; 163():105319. PubMed ID: 33246172 [TBL] [Abstract][Full Text] [Related]
4. Impact of ursodeoxycholic acid on circulating lipid concentrations: a systematic review and meta-analysis of randomized placebo-controlled trials. Simental-Mendía LE; Simental-Mendía M; Sánchez-García A; Banach M; Serban MC; Cicero AFG; Sahebkar A Lipids Health Dis; 2019 Apr; 18(1):88. PubMed ID: 30954082 [TBL] [Abstract][Full Text] [Related]
5. Effect of Hydroxychloroquine on Lipid Levels: A Systematic Review and Metaanalysis. Simental-Mendía LE; Simental-Mendía M; Sánchez-García A; Linden-Torres E Curr Pharm Des; 2021; 27(40):4133-4139. PubMed ID: 34176459 [TBL] [Abstract][Full Text] [Related]
6. Effect of magnesium supplementation on lipid profile: a systematic review and meta-analysis of randomized controlled trials. Simental-Mendía LE; Simental-Mendía M; Sahebkar A; Rodríguez-Morán M; Guerrero-Romero F Eur J Clin Pharmacol; 2017 May; 73(5):525-536. PubMed ID: 28180945 [TBL] [Abstract][Full Text] [Related]
7. The effects of sodium glucose co-transporter (SGLT) 2 inhibitors on hematocrit levels: a systematic review and meta-analysis of randomized controlled trials. Wang X; Fu R; Liu H; Ma Y; Qiu X; Dong Z Ann Palliat Med; 2021 Jun; 10(6):6467-6481. PubMed ID: 34118855 [TBL] [Abstract][Full Text] [Related]
8. Nigella sativa (black seed) effects on plasma lipid concentrations in humans: A systematic review and meta-analysis of randomized placebo-controlled trials. Sahebkar A; Beccuti G; Simental-Mendía LE; Nobili V; Bo S Pharmacol Res; 2016 Apr; 106():37-50. PubMed ID: 26875640 [TBL] [Abstract][Full Text] [Related]
9. Effects of α-linolenic acid intake on blood lipid profiles:a systematic review and meta-analysis of randomized controlled trials. Yue H; Qiu B; Jia M; Liu W; Guo XF; Li N; Xu ZX; Du FL; Xu T; Li D Crit Rev Food Sci Nutr; 2021; 61(17):2894-2910. PubMed ID: 32643951 [TBL] [Abstract][Full Text] [Related]
10. Effect of Sodium-Glucose Cotransport-2 Inhibitors on Blood Pressure in People With Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of 43 Randomized Control Trials With 22 528 Patients. Mazidi M; Rezaie P; Gao HK; Kengne AP J Am Heart Assoc; 2017 May; 6(6):. PubMed ID: 28546454 [TBL] [Abstract][Full Text] [Related]
11. Effect of sodium-glucose transporter 2 inhibitors on sarcopenia in patients with type 2 diabetes mellitus: a systematic review and meta-analysis. Zhang S; Qi Z; Wang Y; Song D; Zhu D Front Endocrinol (Lausanne); 2023; 14():1203666. PubMed ID: 37465122 [TBL] [Abstract][Full Text] [Related]
12. Effects of sodium glucose cotransporter 2 inhibitors on risk of dyslipidemia among patients with type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials. Li D; Wu T; Wang T; Wei H; Wang A; Tang H; Song Y Pharmacoepidemiol Drug Saf; 2020 May; 29(5):582-590. PubMed ID: 32124527 [TBL] [Abstract][Full Text] [Related]
13. Effects of Sodium/Glucose Cotransporter 2 (SGLT2) Inhibitors on Cardiovascular and Metabolic Outcomes in Patients Without Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized-Controlled Trials. Teo YH; Teo YN; Syn NL; Kow CS; Yoong CSY; Tan BYQ; Yeo TC; Lee CH; Lin W; Sia CH J Am Heart Assoc; 2021 Feb; 10(5):e019463. PubMed ID: 33625242 [TBL] [Abstract][Full Text] [Related]
14. A PRISMA-compliant systematic review and meta-analysis of randomized controlled trials investigating the effects of statin therapy on plasma lipid concentrations in HIV-infected patients. Banach M; Dinca M; Ursoniu S; Serban MC; Howard G; Mikhailidis DP; Nicholls S; Lip GYH; Glasser S; Martin SS; Muntner P; Rysz J; Toth PP; Sahebkar A; Pharmacol Res; 2016 Sep; 111():343-356. PubMed ID: 27350264 [TBL] [Abstract][Full Text] [Related]
15. Efficacy and Safety of Evacetrapib for Modifying Plasma Lipids: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Sahebkar A; Simental-Mendía LE; Guerrero-Romero F; Golledge J; Watts GF Curr Pharm Des; 2016; 22(5):595-608. PubMed ID: 26601964 [TBL] [Abstract][Full Text] [Related]
16. The effects of tocotrienol supplementation on lipid profile: A meta-analysis of randomized controlled trials. Zuo S; Wang G; Han Q; Xiao H; O Santos H; Avelar Rodriguez D; Khani V; Tang J Complement Ther Med; 2020 Aug; 52():102450. PubMed ID: 32951713 [TBL] [Abstract][Full Text] [Related]
17. The Effects of L-Carnitine Supplementation on Serum Lipids: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Fathizadeh H; Milajerdi A; Reiner Ž; Kolahdooz F; Chamani M; Amirani E; Asemi Z Curr Pharm Des; 2019; 25(30):3266-3281. PubMed ID: 31470778 [TBL] [Abstract][Full Text] [Related]
18. Effects of sodium-glucose cotransporter 2 inhibitors on non-alcoholic fatty liver disease in patients with type 2 diabetes: A meta-analysis of randomized controlled trials. Xing B; Zhao Y; Dong B; Zhou Y; Lv W; Zhao W J Diabetes Investig; 2020 Sep; 11(5):1238-1247. PubMed ID: 32083798 [TBL] [Abstract][Full Text] [Related]
19. Elevated serum magnesium associated with SGLT2 inhibitor use in type 2 diabetes patients: a meta-analysis of randomised controlled trials. Tang H; Zhang X; Zhang J; Li Y; Del Gobbo LC; Zhai S; Song Y Diabetologia; 2016 Dec; 59(12):2546-2551. PubMed ID: 27628105 [TBL] [Abstract][Full Text] [Related]
20. Effects of dehydroepiandrosterone (DHEA) supplementation on the lipid profile: A systematic review and dose-response meta-analysis of randomized controlled trials. Qin Y; O Santos H; Khani V; Tan SC; Zhi Y Nutr Metab Cardiovasc Dis; 2020 Aug; 30(9):1465-1475. PubMed ID: 32675010 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]